procella.se | Procella Therapeutics AB

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: /wp-admin/ Allow:

Meta Tags

Title	Procella Therapeutics AB - Cell Therapy
Description	Cell therapy solutions in a Procella Therapeutics AB is a biotech company focused on developing cardiac stem cell technology with the aim of treating heart
Keywords	N/A

Server Information

WebSite	procella.se
Host IP	5.226.34.199
Location	Sweden

Related Websites

                        Site
                        Rank
                    

More to Explore

procella.se Valuation

US$2,192,502

Last updated: 2023-05-17 02:16:18

procella.se has Semrush global rank of 4,827,500. procella.se has an estimated worth of US$ 2,192,502, based on its estimated Ads revenue. procella.se receives approximately 252,981 unique visitors each day. Its web server is located in Sweden, with IP address 5.226.34.199. According to SiteAdvisor, procella.se is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$2,192,502
Daily Ads Revenue	US$2,024
Monthly Ads Revenue	US$60,716
Yearly Ads Revenue	US$728,586
Daily Unique Visitors	16,866
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
procella.se.	A	3060	IP: 5.226.34.199
procella.se.	NS	3600	NS Record: ns1.loopia.se.
procella.se.	NS	3600	NS Record: ns2.loopia.se.
procella.se.	MX	449	MX Record: 10 Procella-se.mail.protection.outlook.com.
procella.se.	TXT	259	TXT Record: v=spf1 include:spf.protection.outlook.com -all

HtmlToTextCheckTime:2023-05-17 02:16:18

Start About Us Portfolio Our Team Careers Collaborations Contact Us Cell therapy solutions in a heartbeat Learn more About Us Based in Stockholm, Procella Therapeutics is an early stage biotechnology company focused on developing cardiac stem cell technology leveraging research from Harvard University and Karolinska Institutet with the aim of treating heart failure. Procella is collaborating with AstraZeneca to take our first cellular product candidate from pre-clinical stage to first-in-human studies and, if successful in early trials, further development towards commercial manufacture.  Vision Procella Therapeutics started in 2018 upon a vision to create the next generation of cell-based therapies for patients running out of options.  Mission Our first mission is to develop a cardiac stem cell therapy for patients with advance heart failure and to do this with focus, drive, persistence, creativity, integrity, and inclusiveness. Why cardiovascular disease? Cardiovascular disease,

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Sun, 27 Feb 2022 09:34:27 GMT
Server: Apache
Location: https://procella.se/
Content-Type: text/html; charset=iso-8859-1

HTTP/1.1 200 OK
Date: Sun, 27 Feb 2022 09:34:27 GMT
Server: Apache
Vary: Accept-Encoding,Cookie
Link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
Content-Security-Policy: upgrade-insecure-requests
Cache-Control: max-age=3600, private, no-store, no-cache, must-revalidate
Content-Type: text/html; charset=UTF-8

procella.se Whois Information

#
state:            active
domain:           procella.se
holder:           lro6204-1798599
created:          2016-01-19
modified:         2021-11-01
expires:          2023-01-19
nserver:          ns1.loopia.se 93.188.0.20
nserver:          ns2.loopia.se 93.188.0.21 2a02:250:ffff::21
dnssec:           signed delegation
registry-lock:    unlocked
status:           ok
registrar:        Loopia AB

procella.se valuation and analysis